Lazertinib mesylate hydrate

SI-7849

Lazertinib mesylate hydrate, >98% (HPLC)

CAS No. : [2411549-88-5]

Synonyms : YH-25448 mesylate hydrate; GNS-1480 mesylate hydrate

IUPAC Name : N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide methanesulfonate hydrate

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
25MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
50MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
100MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
250MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026
500MG	Request A Quote		Back Order	Estimated to ship on 04 October 2026

Applications : Lazertinib mesylate hydrate is a BBB‑penetrant third‑generation EGFR‑TKI that also inhibits ABCB1/ABCG2 and activates TRPA1, producing antitumor, chemosensitizing, and sensory‑neuron effects.

References : Oh S. Y. et al.: Cell Rep. Med., 6(2), 101929, 2025; Matsui Y. et al.: Cancer Sci., 115(10), 3333-3345. 2024; Kim H. et al.: J. Pain, 25(5), 104435, 2024.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.